Torrent Pharma executes SPA to acquire 2.41% stake in J.B. Chemicals & Pharmaceuticals

04 Jul 2025 Evaluate

Torrent Pharmaceuticals has executed share purchase agreement (SPA) with employees of the J.B. Chemicals & Pharmaceuticals for acquisition of up to 38,75,056 equity shares, representing 2.41% equity share capital of the J.B. Chemicals & Pharmaceuticals on a fully diluted basis, for a cash consideration, at a price of Rs 1,600 per equity share aggregating to a total consideration of around Rs 620 crore. Further, the company may acquire the balance equity shares forming part of the Potential Acquisition i.e., up to 6,24,726 equity shares, representing 0.39% of the equity share capital of the J.B. Chemicals & Pharmaceuticals, on a fully diluted basis, from certain other employees of the J.B. Chemicals & Pharmaceuticals, at a price not exceeding Rs 1,600 per equity share.

Earlier, the company’s board had approved the acquisition of up to 44,99,782 equity shares, representing up to 2.80% of the equity share capital of the J.B. Chemicals & Pharmaceuticals on a fully diluted basis, from certain employees.

Torrent Pharmaceuticals (Torrent Pharma) is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Torrent Pharma Share Price

3773.70 -27.95 (-0.74%)
05-Dec-2025 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1521.50
Zydus Lifesciences 933.10
Lupin 2089.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×